Synovial Fibroblast 3.1: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 1 of 2) - Dataset (ID:20234)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2645 | Tofacitinib | 0.3 | uM | 2 | CTACK | 15.0 | 61 | ||||
N2645 | 2 | CTACK | 16.0 | 45 | |||||||
RA2708 | Tofacitinib | 0.3 | uM | 2 | CTACK | 16.0 | 49 | ||||
RA2708 | 2 | CTACK | 15.0 | 51 | |||||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 2 | CTACK | 15.0 | 62 | |
RA2159 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 2 | CTACK | 16.5 | 70 | |
N2645 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 2 | CTACK | 16.0 | 66 | |
N2645 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 2 | CTACK | 15.5 | 58 | |
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 2 | CTACK | 14.0 | 57 | |
RA2708 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 2 | CTACK | 14.5 | 60 | |
RA2159 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 2 | CTACK | 14.0 | 46 | |
RA2159 | TNF-a | 100 | ng/mL | 2 | CTACK | 16.5 | 54 | ||||
N2645 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 2 | CTACK | 14.0 | 53 | |
N2645 | TNF-a | 100 | ng/mL | 2 | CTACK | 13.0 | 47 | ||||
RA2708 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 2 | CTACK | 17.0 | 25 | |
RA2708 | TNF-a | 100 | ng/mL | 2 | CTACK | 18.0 | 38 | ||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 2 | CTACK | 32.0 | 45 | |
RA2159 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 2 | CTACK | 24.0 | 59 | |
N2645 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 2 | CTACK | 31.0 | 53 | |
N2645 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 2 | CTACK | 25.0 | 62 | |
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 2 | CTACK | 32.5 | 58 | |
RA2708 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 2 | CTACK | 26.0 | 39 | |
RA2159 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 2 | CTACK | 27.0 | 44 | |
RA2159 | IL-1 alpha | 100 | ng/mL | 2 | CTACK | 30.0 | 55 | ||||
N2645 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 2 | CTACK | 29.0 | 46 |